We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+29.06%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$635M
AUM Growth
-$118M
Cap. Flow
-$205M
Cap. Flow %
-32.24%
Top 10 Hldgs %
8.47%
Holding
431
New
122
Increased
24
Reduced
159
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Healthcare 21.95%
3 Industrials 15.49%
4 Financials 10.29%
5 Consumer Discretionary 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXTI icon
26
AXT Inc
AXTI
$2.8B
$3.9M 0.61%
672,506
+10,399
+2% +$64.6K
TWNK
27
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$3.89M 0.61%
245,019
+9,677
+4% +$145K
TGTX icon
28
TG Therapeutics
TGTX
$8.4B
$3.86M 0.61%
+330,950
New +$2.38M
ACRS icon
29
Aclaris Therapeutics
ACRS
$744M
$3.85M 0.61%
129,066
-9,550
-7% -$275K
KATE
30
DELISTED
Kate Spade & Company
KATE
$3.83M 0.6%
+165,020
New +$3.45M
OCLR
31
DELISTED
Oclaro Inc.
OCLR
$3.82M 0.6%
388,893
-82,057
-17% -$771K
IBTX
32
DELISTED
Independent Bank Group, Inc.
IBTX
$3.81M 0.6%
59,186
-6,279
-10% -$396K
MB
33
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$3.8M 0.6%
138,326
-53,822
-28% -$1.38M
ECHO
34
EchoStar
ECHO
$24.9B
$3.79M 0.6%
82,054
+5,671
+7% +$247K
BCO icon
35
Brink's
BCO
$4.87B
$3.74M 0.59%
+70,023
New +$3.41M
MMSI icon
36
Merit Medical Systems
MMSI
$4.67B
$3.74M 0.59%
+129,529
New +$3.63M
JBTM
37
JBT Marel
JBTM
$7.59B
$3.74M 0.59%
42,539
+1,463
+4% +$127K
GKOS icon
38
Glaukos
GKOS
$8.89B
$3.71M 0.58%
72,298
-5,644
-7% -$246K
VC icon
39
Visteon
VC
$2.85B
$3.71M 0.58%
37,850
+2,308
+6% +$213K
CLVS
40
DELISTED
Clovis Oncology, Inc.
CLVS
$3.69M 0.58%
+57,882
New +$3.52M
PFBC icon
41
Preferred Bank
PFBC
$1.25B
$3.67M 0.58%
68,351
-18,976
-22% -$1.03M
EXAS
42
DELISTED
Exact Sciences
EXAS
$3.66M 0.58%
+154,911
New +$3.07M
FLXN
43
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3.57M 0.56%
132,595
+95,713
+260% +$1.95M
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.55M 0.56%
+96,225
New +$2.42M
AVTA
45
DELISTED
Avantax, Inc. Common Stock
AVTA
$3.54M 0.56%
+204,812
New +$3.21M
TSRO
46
DELISTED
TESARO, Inc.
TSRO
$3.52M 0.55%
22,871
+1,142
+5% +$186K
KPTI icon
47
Karyopharm Therapeutics
KPTI
$161M
$3.46M 0.55%
+17,974
New +$2.89M
CSII
48
DELISTED
Cardiovascular Systems, Inc.
CSII
$3.45M 0.54%
121,923
-8,040
-6% -$214K
AVXS
49
DELISTED
AveXis, Inc. Common Stock
AVXS
$3.44M 0.54%
45,215
-2,980
-6% -$184K
RP
50
DELISTED
RealPage, Inc.
RP
$3.37M 0.53%
96,477
-6,360
-6% -$208K

Similar funds

EAM Investors's Q1 2017 Portfolio in Review

As of Q1 2017, EAM Investors held 431 positions worth $635M, down 16% from $752M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

EAM Investors withdrew a net $205M in Q1 2017, closing 124 positions and reducing 159 holdings. Its most notable exit was Horizon Global Corporation, an estimated $7.38M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, EAM Investors opened a new position in Teladoc Health worth $4.58M.

  • EAM Investors's largest Q1 2017 buy was Teladoc Health: 183,360 shares worth $4.58M.
  • EAM Investors added most to Azenta in Q1 2017, an estimated $2.29M increase.
  • EAM Investors's biggest Q1 2017 reduction was Hudson Technologies, cutting an estimated $4.57M.
  • EAM Investors fully exited Horizon Global Corporation in Q1 2017, selling an estimated $7.38M.
  • EAM Investors's ten largest holdings make up 8.5% of its $635M portfolio in Q1 2017.
  • EAM Investors opened 122 new positions and closed 124 in Q1 2017.
  • EAM Investors's portfolio value fell 16% quarter-over-quarter to $635M.

Based on EAM Investors's 13F filing for Q1 2017, filed 10 May 2017.